{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2020:MADYIJGDU45C7U3Z3TSE377O2P","short_pith_number":"pith:MADYIJGD","schema_version":"1.0","canonical_sha256":"60078424c3a73a2fd379dce44dffeed3fe1319419b66c1ee53d2535c58c90d6e","source":{"kind":"arxiv","id":"2005.13285","version":3},"attestation_state":"computed","paper":{"title":"PaccMann$^{RL}$ on SARS-CoV-2: Designing antiviral candidates with conditional generative models","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":["cs.LG","stat.ML"],"primary_cat":"q-bio.QM","authors_text":"Greta Markert, Jannis Born, Joris Cadow, Mar\\'ia Rodr\\'iguez Mart\\'inez, Matteo Manica, Modestas Filipavicius, Nil Adell Mill","submitted_at":"2020-05-27T11:30:15Z","abstract_excerpt":"With the fast development of COVID-19 into a global pandemic, scientists around the globe are desperately searching for effective antiviral therapeutic agents. Bridging systems biology and drug discovery, we propose a deep learning framework for conditional de novo design of antiviral candidate drugs tailored against given protein targets. First, we train a multimodal ligand--protein binding affinity model on predicting affinities of antiviral compounds to target proteins and couple this model with pharmacological toxicity predictors. Exploiting this multi-objective as a reward function of a c"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2005.13285","kind":"arxiv","version":3},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"q-bio.QM","submitted_at":"2020-05-27T11:30:15Z","cross_cats_sorted":["cs.LG","stat.ML"],"title_canon_sha256":"36a715b52140edcefbf6905f1d76e26fcfa09c81e6cb1258c0763c0e3d7d0540","abstract_canon_sha256":"1db61838ac99ef0f5b4ef4ca1833390644564feaa73e045446a049401a703f88"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T01:53:20.560249Z","signature_b64":"h5PjH8KwYpE20eDK1OHawA6qlxWb1K8TRAE0SXLUKx/M4ddgiRVIlu5AaqijVDyKarRmRU9xrTliwkO1TQ6EAA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"60078424c3a73a2fd379dce44dffeed3fe1319419b66c1ee53d2535c58c90d6e","last_reissued_at":"2026-07-05T01:53:20.559804Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T01:53:20.559804Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"PaccMann$^{RL}$ on SARS-CoV-2: Designing antiviral candidates with conditional generative models","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":["cs.LG","stat.ML"],"primary_cat":"q-bio.QM","authors_text":"Greta Markert, Jannis Born, Joris Cadow, Mar\\'ia Rodr\\'iguez Mart\\'inez, Matteo Manica, Modestas Filipavicius, Nil Adell Mill","submitted_at":"2020-05-27T11:30:15Z","abstract_excerpt":"With the fast development of COVID-19 into a global pandemic, scientists around the globe are desperately searching for effective antiviral therapeutic agents. Bridging systems biology and drug discovery, we propose a deep learning framework for conditional de novo design of antiviral candidate drugs tailored against given protein targets. First, we train a multimodal ligand--protein binding affinity model on predicting affinities of antiviral compounds to target proteins and couple this model with pharmacological toxicity predictors. Exploiting this multi-objective as a reward function of a c"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2005.13285","kind":"arxiv","version":3},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2005.13285/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2005.13285","created_at":"2026-07-05T01:53:20.559862+00:00"},{"alias_kind":"arxiv_version","alias_value":"2005.13285v3","created_at":"2026-07-05T01:53:20.559862+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2005.13285","created_at":"2026-07-05T01:53:20.559862+00:00"},{"alias_kind":"pith_short_12","alias_value":"MADYIJGDU45C","created_at":"2026-07-05T01:53:20.559862+00:00"},{"alias_kind":"pith_short_16","alias_value":"MADYIJGDU45C7U3Z","created_at":"2026-07-05T01:53:20.559862+00:00"},{"alias_kind":"pith_short_8","alias_value":"MADYIJGD","created_at":"2026-07-05T01:53:20.559862+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/MADYIJGDU45C7U3Z3TSE377O2P","json":"https://pith.science/pith/MADYIJGDU45C7U3Z3TSE377O2P.json","graph_json":"https://pith.science/api/pith-number/MADYIJGDU45C7U3Z3TSE377O2P/graph.json","events_json":"https://pith.science/api/pith-number/MADYIJGDU45C7U3Z3TSE377O2P/events.json","paper":"https://pith.science/paper/MADYIJGD"},"agent_actions":{"view_html":"https://pith.science/pith/MADYIJGDU45C7U3Z3TSE377O2P","download_json":"https://pith.science/pith/MADYIJGDU45C7U3Z3TSE377O2P.json","view_paper":"https://pith.science/paper/MADYIJGD","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2005.13285&json=true","fetch_graph":"https://pith.science/api/pith-number/MADYIJGDU45C7U3Z3TSE377O2P/graph.json","fetch_events":"https://pith.science/api/pith-number/MADYIJGDU45C7U3Z3TSE377O2P/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/MADYIJGDU45C7U3Z3TSE377O2P/action/timestamp_anchor","attest_storage":"https://pith.science/pith/MADYIJGDU45C7U3Z3TSE377O2P/action/storage_attestation","attest_author":"https://pith.science/pith/MADYIJGDU45C7U3Z3TSE377O2P/action/author_attestation","sign_citation":"https://pith.science/pith/MADYIJGDU45C7U3Z3TSE377O2P/action/citation_signature","submit_replication":"https://pith.science/pith/MADYIJGDU45C7U3Z3TSE377O2P/action/replication_record"}},"created_at":"2026-07-05T01:53:20.559862+00:00","updated_at":"2026-07-05T01:53:20.559862+00:00"}